Abstract:Nur77 (also known as TR3 and NGFI-B) is a nuclear orphan receptor that in response to various stimuli can translocate from the nucleus to the mitochondria, bind Bcl-2, and induce a conformational change in Bcl-2 that exposes its BH3 domain. This conformational change of Bcl-2 transforms this protein into a pro-apoptotic molecule that can induce cytochrome c release and apoptosis (Cell 116:527, 2004). Interestingly, in acute myeloid leukemia (AML) cell lines and blasts, Nur77 is absent. We have recently generated a nine amino acid peptide from the Nur77 protein (TR3) that is capable of inducing the same pro-apoptotic conformational change in Bcl-2 that Nur77 elicits (manuscript submitted). We tested the hypothesis that a cell-permeable version of this peptide can induce Bcl-2-dependent apoptosis in AML cells and AML stem cells. Primary AML samples (n=6) were incubated with 20 μM control or TR3 peptide for 24 hrs. Induction of apoptosis was measured as CD34+38−123+ PS/Annexin V+ by multiparametric flow cytometry. Our results demonstrate that the L-enantiomer form of TR3 indeed induces apoptosis in total AML cells (60%, p=0.001) and CD34+38−123+ stem cells (67%, p=0.001), as compared to control peptide. Bax expression did not affect the peptide's ability to induce apoptosis, as wild-type HCT116 cells and HCT116 cells deficient in Bax showed similar levels of apoptosis after treatment with the TR3 peptide. However, Bcl-2 expression was shown to be critical since lentiviral shRNA ablation of Bcl-2 in KG1 cells completely prevented induction of apoptosis by TR3 peptides. We conclude that the TR3 peptide is a potent inducer of apoptosis that mimics the action of Nur77 on Bcl-2 at the mitochondrial level. These results suggest that the Nur77 peptide or compounds that mimic this peptide may have utility as a novel therapeutic agent against Bcl-2 expressing cancers and leukemias.

Targeting Nur77 Translocation.

Nur77: a Potential Therapeutic Target in Cancer

Dual roles of Nur77 in selective regulation of apoptosis and cell cycle by TPA and ATRA in gastric cancer cells.

Phase Separation of Nur77 Mediates XS561-induced Apoptosis by Promoting the Formation of Nur77/Bcl-2 Condensates

Characteristics of Nur77 and its ligands as potential anticancer compounds (Review).

Retinoid X Receptor Regulates Nur77/TR3-Dependent Apoptosis by Modulating Its Nuclear Export and Mitochondrial Targeting

Regulation of Nur77 nuclear export by c-Jun N-terminal kinase and Akt

Retinoid X Receptor Regulates Nur77/Thyroid Hormone Receptor 3-Dependent Apoptosis by Modulating Its Nuclear Export and Mitochondrial Targeting

Characteristics of Nur77 and Its Ligands As Potential Anticancer Compounds (Review)

PKA/Smurf1 signaling-mediated stabilization of Nur77 is required for anticancer drug cisplatin-induced apoptosis

Dual roles of orphan nuclear receptor TR3/Nur77/NGFI-B in mediating cell survival and apoptosis.

Regulation of Nur77 expression by β-catenin and its mitogenic effect in colon cancer cells.

A Unique Pharmacophore for Activation of the Nuclear Orphan Receptor Nur77 in Vivo and in Vitro

Modulation Of The Nur77-Bcl-2 Apoptotic Pathway By P38 Alpha Mapk

A Novel Peptide Containing a Nine Amino Acid Sequence from Nur77 Induces Bcl-2-Dependent Apoptosis in AML.

Mitochondrial Translocation of Nur77 Mediates Cardiomyocyte Apoptosis

Inhibition of Β-Catenin Signaling by Nongenomic Action of Orphan Nuclear Receptor Nur77

Nuclear Receptor Nur77 Facilitates Melanoma Cell Survival under Metabolic Stress by Protecting Fatty Acid Oxidation.

Orphan Nuclear Receptor Nur77 Promotes Colorectal Cancer Invasion and Metastasis by Regulating MMP-9 and E-cadherin.

Moving Nuclear Receptor Nur77 to Damaged Mitochondria for Clearance by Mitophagy.

A Role for the Orphan Steroid Receptor Nur77 in Apoptosis Accompanying Antigen-Induced Negative Selection.